Ishiguchi, Hironori
Abdul-Rahim, Azmil H. https://orcid.org/0000-0002-1318-4027
Huang, Bi
Lam, Steven Ho Man
Liu, Yang
Olshansky, Brian
Chao, Tze-Fan
Huisman, Menno V.
Lip, Gregory Y. H.
,
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 7 May 2024
Accepted: 11 September 2024
First Online: 25 September 2024
Declarations:
:
: HI, BH, SHML, and YL report no conflicts of interest.BO reports one disclosure AstraZeneca DSMB, Consultant for Boehringer Ingelheim.TFC reports honoraria for lectures from Boehringer Ingelheim, Bayer, Pfizer, and Daiichi Sankyo, outside the submitted work.MVH reports receiving research grants from the Dutch Healthcare Fund, Dutch Heart Foundation, BMS-Pfizer, Bayer Healthcare, and Boehringer Ingelheim and consulting fees from BMS-Pfizer, Bayer Healthcare, and Boehringer Ingelheim to the institution.GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-PI of the AFFIRMO project on multimorbidity in AF (grant agreement No 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (grant agreement No 101136244), and ARISTOTELES project on artificial intelligence for management of chronic long-term conditions (grant agreement No 101080189), which are all funded by the EU’s Horizon Europe Research and Innovation programme.AHAR reports Member of the Editorial Board of Stroke and European Stroke Journal.
: The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents.